High Court Could Upend Rare Post-Mensing Loss For Generics
Mutual Pharmaceutical Co. asked the U.S. Supreme Court on Tuesday to reverse the First Circuit's ruling that design defect claims can be leveled against generic-drug companies, a bid that could extinguish...To view the full article, register now.
Already a subscriber? Click here to view full article